Currency in USD
Earnings Estimate | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|
No. of Analysts | 0 | 0 | 3 | 3 |
Avg. Estimate | 0 | 0 | 4.03 | 4.55 |
Low Estimate | 0 | 0 | 3.99 | 4.4 |
High Estimate | 0 | 0 | 4.1 | 4.74 |
Year Ago EPS | 0.9 | 0.97 | 3.86 | 4.03 |
Revenue Estimate | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|
No. of Analysts | 1 | 1 | 4 | 4 |
Avg. Estimate | 9.42B | 9.6B | 40.55B | 43.19B |
Low Estimate | 9.42B | 9.6B | 39.81B | 41.95B |
High Estimate | 9.42B | 9.6B | 41.09B | 44.21B |
Year Ago Sales | 8.45B | 8.99B | 37.7B | 40.55B |
Sales Growth (year/est) | 11.60% | 6.80% | 7.60% | 6.50% |
Earnings History | 3/30/2023 | 6/29/2023 | 9/29/2023 | 12/30/2023 |
---|
EPS Est. | 0.82 | 0.87 | 1.14 | 0.76 |
EPS Actual | 0.9 | 0.97 | 1.28 | 0.72 |
Difference | 0.08 | 0.1 | 0.14 | -0.04 |
Surprise % | 9.80% | 11.50% | 12.30% | -5.30% |
EPS Trend | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|
Current Estimate | 0 | 0 | 4.03 | 4.55 |
7 Days Ago | 0 | 0 | 4.04 | 4.56 |
30 Days Ago | 0 | 0 | 3.99 | 4.45 |
60 Days Ago | 0 | 0 | 4.04 | 4.48 |
90 Days Ago | 0 | 0 | 3.94 | 4.35 |
EPS Revisions | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|
Up Last 7 Days | N/A | N/A | N/A | N/A |
Up Last 30 Days | N/A | N/A | N/A | 1 |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | N/A | N/A | N/A |
Growth Estimates | GSK | Industry | Sector(s) | S&P 500 |
---|
Current Qtr. | N/A | N/A | N/A | N/A |
Next Qtr. | N/A | N/A | N/A | N/A |
Current Year | 4.40% | N/A | N/A | N/A |
Next Year | 12.90% | N/A | N/A | N/A |
Next 5 Years (per annum) | 4.80% | N/A | N/A | N/A |
Past 5 Years (per annum) | -2.43% | N/A | N/A | N/A |